Theralase Technologies Inc. V.TLT

Patients 20 & 21

[99942Apophis]

Patient 20 announced June 11/2021 just hit 360 days and although patients 21 to 24 were announced August 30/2021 my guesstimate is patient 21 will hit 360 days very close to the AGM.
By years end (2022) we should see 24 patients hitting 450 days with a strong possibility of patient 25 getting in too.

[consultant99]

My look based on the charts is 26 patients will be completed their 450 day scans by year end.  Based on the goal of applying for BTD in Q4 once 25 scans have been completed Imam guessing the 25th will be done in November. On a totally different topic I have recently been pondering on how patients can have a NR after a treatment. Surely the drug is absorbed by cancerous cells and activating

[99942Apophis]

consultant99 wrote My look based on the charts is 26 patients will be completed their 450 day scans by year end.  Based on the goal of applying for BTD in Q4 once 25 scans have been completed Imam guessing the 25th will be done in November. On a totally different topic I have recently been pondering on how patients can have a NR after a treatment. Surely the drug is absorbed by cancerous

[langosta]

Never thought of it like that. Surely if treatments are administered correctly there can only be Complete Response or Partial Response. Would there be a cut off % for Partial Response where anything below cut off would be considered as No Response.

[Eoganacht]

Hi 99942Apophis - You're right - as of May 28, 2021 only 19 patients had been treated and on June 11, 2021 it was announced that the 20th patient had been treated. So the 20th patient won't reach 450 days until somewhere between August 21st and September 4th 2022. In the MD&A before showing the table of results for the first 20 patients it says: "An analysis of the first 20

[99942Apophis]

Eoganacht my answer will either make you laugh or cry, I use my math only to calculate time frames which are on a hand crafted chart I keep on my coffee table. I have given up on their information as it always leaves me uncertain and if read in the morning I end up drinking way too much coffee, if read in the afternoon then I drink way too much beer with a vodka chaser!

[Eoganacht]

Hi 99942Apophis - I think I'm going to follow your example. The more I try to understand the more confused I get. As of now I don't understand what that 20 patient table in the MD&A is all about. I'm just going to wait until they tell us more.

[Rumpl3StiltSkin]

Ha Ha, I applaud you gents keep trying to crunch these numbers. For me is TLT's solution potentially still better than Keytruda? Yes. I think that the final figures will be way better than Keytruda. Which is valued in the $Billions.

[DJDawg]

I have crunched the numbers many times and there are always that don't work. They don't present it clearly. Regarding the 20 patients. For the total 41, 19 are pending. Leaving 22 that are done done. If you remove the 3 1b patients that is 19. So not enough phase 2 patients to make a table of 20. My belief is that they are counting the 1b patients in the 20. The wording about "

[Eoganacht]

Thanks DJDawg. That's very helpful.

[Eoganacht]

Maybe they also excluded patient 4 from the phase 1b who had metastatic cancer and would not have been evaluated after 138 days. That would make 20.

[DJDawg]

Yes! That makes sense as it fits the wording for that particular table.

[Eoganacht]

On the other hand, 5 of the first 12 phase 2 patients were also removed from the study so who really knows what's going on.

[StevenBirch]

Maybe the first question at the AGM should be "why are the numbers presented in such a confusing fashion?" 

[skier59]

Duh Ya !

[Oilminerdeluxe]

Anyone going to the AGM who likes to ask questions, feel free to ask if they can present their data so even regular folks can understand it. We should not have to guess what they mean. It is outright insulting to shareholders. Hopefully, they will make a good day out of the AGM

[Gooseybear]

Perhaps the regulators are also having a hard time understanding the numbers, and from having worked with regulators for many years, if it's not documented well, it doesn't exist. TLTF track record not so great so they need to be extremely clear and concise.

[Infinity]

Goisey, Your observations on clarity is spot on!!!

[langosta]

It's called 'deliberate obfuscation'.